substance p has been researched along with dinoprostone in 168 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (10.71) | 18.7374 |
| 1990's | 63 (37.50) | 18.2507 |
| 2000's | 64 (38.10) | 29.6817 |
| 2010's | 19 (11.31) | 24.3611 |
| 2020's | 4 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Acker, GM; Advenier, C; Devillier, P; Frossard, N; Marsac, J; Regoli, D | 1 |
| Brunelleschi, S; Ceni, E; Fantozzi, R; Giotti, A; Parenti, A | 1 |
| Busija, DW; Chen, J | 1 |
| Håkanson, R; Wallengren, J | 1 |
| Klingberg, DK; Nicol, GD; Vasko, MR | 1 |
| Baas, AA; Evers, NA; van der Meer, C | 1 |
| Koelbel, CB; Leduc, L; Mayer, EA; Snape, WJ; Vandeventer, G | 1 |
| Herbort, CP; Mochizuki, M; Nishi, M; Okumura, A | 1 |
| Fukuoka, M; Gomi, Y; Ito, Y; Kakiuchi, M; Kato, H; Morikawa, K | 1 |
| Blancuzzi, VJ; Jeng, AY; O'Byrne, EM; Peppard, J; Simke, JP; Wilson, DE; Wong, M | 1 |
| Humphries, RG; Leff, P; O'Connor, SE; Tomlinson, W | 1 |
| Marriott, DR; Wilkin, GP; Wood, JN | 1 |
| Bull, HA; Cohen, J; Dowd, PM | 1 |
| Mandrek, K; Milenov, K | 1 |
| Blancuzzi, V; Jeng, AY; O'Byrne, EM; Peppard, J; Simke, JP; Wilson, D; Wong, M | 1 |
| Gustafsson, LE; Hedqvist, P; Persson, MG | 1 |
| Costa, ME; Hersh, LB; Katz, KH; Ojeda, SR | 1 |
| Brain, SD; Williams, TJ | 1 |
| Denko, CW; Gabriel, P | 1 |
| Abdel-Latif, AA; Akhtar, RA; Yousufzai, SY | 1 |
| Brain, SD; MacIntyre, I; Morris, HR; Tippins, JR; Williams, TJ | 1 |
| Carson, DA; Lotz, M; Vaughan, JH | 1 |
| Fujiwara, H; Katayama, T; Sakamoto, T; Yamamoto, K | 1 |
| Kumazawa, T; Mizumura, K; Sato, J | 1 |
| Allen, J; Andersson, KE; Forman, A; Hansen, V; Maigaard, S | 1 |
| Hayashi, K; Ito, K; Murakami, T; Nakashima, T | 1 |
| Herbort, CP; Mochizuki, M; Okumura, A | 1 |
| Bathon, JM; Krackow, K; Proud, D; Wigley, FM | 1 |
| Fjellner, B; Hägermark, O | 1 |
| Baccaglini, PI; Hogan, PG | 1 |
| Akai, M; Inoki, R; Kudo, T; Nishimoto, T; Shiosaka, S; Tohyama, M | 1 |
| Bynke, G; Håkanson, R; Hörig, J | 1 |
| Abdel-Hakim, A; Abdel-Rahman, M; Elhilali, M; Galeano, C; Hassouna, M; Rioux, F; St-Pierre, S | 1 |
| Gerstenberg, T; Hald, T; Klarskov, P | 1 |
| Capen, CC; Horton, JE; McCauley, LK; Nohutcu, RM; Rosol, TJ | 1 |
| Almaraz, L; Gómez-Niño, A; González, C; Pérez-García, MT | 1 |
| Di Fiore, MM; Gobbetti, A; Zerani, M | 1 |
| Campbell, WB; Vasko, MR; Waite, KJ | 1 |
| Davison, JS; Mathison, R | 2 |
| Cadman, ED; Lee, CM; Witte, DG | 1 |
| Botte, V; Di Fiore, MM; Gobbetti, A; Zerani, M | 1 |
| Bowles, W; Garry, MG; Hargreaves, KM; Jackson, DL; Roszkowski, MT; Swift, JQ | 1 |
| Izumi, H; Kuwazuru, S; Mori, H; Nakamura, I; Ozima, Y; Taguchi, S; Uchiyama, T | 1 |
| Gobbetti, A; Zerani, M | 2 |
| Levi-Schaffer, F; Slavin, S; Vourka-Karussis, U | 1 |
| Betts, WH; Halliday, DA; McNeil, JD; Scicchitano, R | 2 |
| Crossman, DC; Dashwood, MR; Fuller, RW; Taylor, GW; Wellings, R | 1 |
| Conlon, JM; Homo-Delarche, F; Kerdelhue, B; Leboulenger, F; Pelletier, G; Vaglini, L; Vaudry, H; Wang, Y | 1 |
| Mulholland, MW; Simeone, DM | 1 |
| Ebihara, A; Fujimura, A; Shiga, T; Sunaga, K | 1 |
| Berti, F; Bianchi, M; Panerai, AE; Rossoni, G; Sacerdote, P | 2 |
| Herold, M; Kähler, CM; Reinisch, N; Wiedermann, CJ | 1 |
| Franks, CM; Hardcastle, J; Hardcastle, PT | 1 |
| Dastmalchi, S; Gold, MS; Levine, JD | 1 |
| White, DM | 1 |
| Seybold, VS; Stucky, CL; Thayer, SA | 1 |
| Abdel-Latif, AA; Marathe, GK; Yousufzai, SY | 1 |
| Fredberg, JJ; Heyder, J; Hubmayr, RD; Moller, W; Panettieri, RA; Planus, E; Shore, SA; Wang, N | 1 |
| Cho, CH; Ko, JK; Tang, F | 1 |
| Alam, M; Kapraali, M; Söderman, C; Theodorsson, E; Uribe, A | 1 |
| Böhm, SK; Bunnett, NW; Caughey, GH; Corvera, CU; Déry, O; Khitin, LM; McConalogue, K; Payan, DG | 1 |
| Aloisi, F; Ambrosini, E; Astolfi, M; Levi, G; Manzini, S; Minghetti, L; Palma, C; Silberstein, FC | 1 |
| Archer, CB; Kennedy, CT; Sabroe, RA | 1 |
| Bjorling, DE; Saban, MR; Saban, R | 1 |
| Bertone, AL; Hardy, J; Masty, J; Muir, WW; O'Dorisio, TM; Weisbrode, SE | 1 |
| Baba, K; Hattori, T; Kobayashi, T; Yoshida, K | 1 |
| Hamada, M; Shirasawa, E; Tsuji, F | 1 |
| Bindslev, N; Christensen, P; Schmidt, P; Skadhauge, E; Thorbøll, JE; Tindholdt, TT | 1 |
| Gruetter, CA; Lemke, S; Spurlock, B; Szarek, JL | 1 |
| Dreshaj, IA; Haxhiu, MA; Martin, RJ; Mhanna, MJ | 1 |
| Averbeck, B; Guthmann, C; Kress, M; Reeh, PW | 1 |
| Chen, P; Hua, XY; Marsala, M; Yaksh, TL | 1 |
| Iwamoto, T; Kohri, H; Noguchi, K; Ohara, M; Sato, S; Senba, E; Yasuda, T | 1 |
| Averbeck, B; Ebersberger, A; Messlinger, K; Reeh, PW | 1 |
| Dirig, DM; Yaksh, TL | 1 |
| Cicha, MZ; Kopp, UC | 2 |
| Ferreira, SH; Tonussi, CR | 1 |
| Cicha, MZ; Farley, DM; Kopp, UC; Smith, LA | 1 |
| Hanioka, T; Matsumori, Y; Matsuse, R; Shizukuishi, S; Takaya, K | 1 |
| Agarwal, RK; Chandna, VK; Kirker-Head, CA; Kumar, MS; Morris, EA; O'Callaghan, MW; Rand, W; Tidwell, A | 1 |
| Bailey, TW; Broome, JT; Evans, AR; Junger, H; Nicol, GD; Sorkin, LS; Southall, MD; Vasko, MR | 1 |
| Depoortere, I; Keith, JC; Peeters, TL; Thijs, T; van Assche, G | 1 |
| Burgess, GM; Davis, CL; Smith, JA | 1 |
| Klede, M; Lischetzki, G; Neisius, U; Petersen, LJ; Rukwied, R; Schmelz, M; Skov, PS; Weidner, C | 1 |
| Campbell, WB; Fujimoto, JM; Rady, JJ | 1 |
| Kamei, J; Onodera, K; Shinoda, H; Taki, K; Zushida, K | 1 |
| Fortner, CN; Lorenz, JN; Paul, RJ | 1 |
| Averbeck, B; Reeh, PW | 1 |
| Cabrini, DA; Calixto, JB; Campos, MM; Cardozo, AH; Rae, GA; Toro, JH | 1 |
| Ebersberger, A | 1 |
| Dreshaj, IA; Ferkol, T; Haxhiu, MA; Kelley, TJ; Martin, RJ; Mhanna, MJ; van Heeckeren, AM | 1 |
| Breyer, RM; Fortner, CN; Paul, RJ | 1 |
| Conway, CM; Dirig, DM; Isakson, PC; Luo, ZD; Svensson, C; Yaksh, TL | 1 |
| Reeh, PW; Roza, C | 1 |
| Allegra, L; Ertl, RF; Kawamoto, M; Kohyama, T; Nakamura, Y; Rennard, SI; Romberger, D; Spurzem, J; Valenti, V; Veys, T | 1 |
| Cicha, MZ; Kopp, UC; Smith, LA | 6 |
| Kawai, M; Mashima, Y; Mochizuki, H; Ogata, M; Yamada, M | 1 |
| Andoh, T; Kuraishi, Y | 1 |
| Andoh, T; Katsube, N; Kuraishi, Y; Maruyama, M | 1 |
| Kopp, S | 1 |
| Bianchi, M; Ferrario, P; Gaspani, L; Limiroli, E | 1 |
| Bolyard, LA; Southall, MD; Vasko, MR | 1 |
| Hosoda, Y; Karaki, S; Kuwahara, A; Shimoda, Y | 1 |
| Geisslinger, G; Meller, ST; Tegeder, L; Zimmermann, J | 1 |
| Kaneyama, K; Miyamaru, M; Nishimura, M; Segami, N; Suzuki, T | 1 |
| Chen, SL; Wang, XF; Xing, FQ | 1 |
| Averbeck, B; Maier, M; Milz, S; Refior, HJ; Schmitz, C | 1 |
| Alves, DL; Caliari, MV; Duarte, ID; Francischi, JN; Maltos, KL; Menezes, GB; Rocha, OA; Santos, JM | 1 |
| Anguita, J; Bost, KL; Halberstadt, CR; Marriott, I; Rasley, A | 1 |
| Cicha, MZ; Hökfelt, T; Kopp, UC; Nakamura, K; Nüsing, RM; Smith, LA | 1 |
| Bozymski, EM; Davies, MJ; Johnson, DA; Morteau, O; Palsson, OS; Sartor, RB; Turner, MJ; Whitehead, WE; Woosley, JT | 1 |
| Dennis, EA; Hua, XY; Lucas, KK; Powell, HC; Svensson, CI; Yaksh, TL | 1 |
| Crentsil, V | 1 |
| Bartfai, T; Fitzsimmons, B; Gu, G; Hua, XY; Kondo, I; Salgado, KF; Yaksh, TL | 1 |
| Dennis, EA; Fitzsimmons, B; Hadjipavlou-Litina, D; Hua, XY; Kokotos, CG; Kokotos, G; Stephens, D; Svensson, CI; Yaksh, TL | 1 |
| Benetti, E; Collino, M; Dianzani, C; Fantozzi, R; Gallicchio, M; Rosa, AC | 1 |
| Bergren, DR | 1 |
| Koon, HW; Moyer, MP; Pothoulakis, C; Rhee, SH; Zhan, Y; Zhao, D | 1 |
| Kasai, K; Kojima, T; Yamaguchi, M | 1 |
| Dudic, A; Giannopoulou, C; Kiliaridis, S | 1 |
| Bley, KR; Clark, R; Jones, RL; Whiting, RL; Wise, H | 1 |
| Dudic, A; Giannopoulou, C; Kiliaridis, S; Mombelli, A | 1 |
| Fujimura, K; Kaneyama, K; Nagao, T; Sato, J; Segami, N; Yoshimura, H | 1 |
| Awad, H; Cardounel, AJ; Chen, Z; Christofi, FL; Cooke, H; Guzman, J; Hassanain, HH; Javed, A; Palmer, J; Suntres, Z; Xue, J; Yu, JG | 1 |
| Jiang, Y; Qian, Y; Zeng, BF; Zhang, XL | 1 |
| Ahaghotu, E; Babu, RJ; Fulzele, SV; Singh, M | 1 |
| Bianchi, M; Ferrario, P; Franchi, S; Sacerdote, P; Sotgiu, ML | 1 |
| Cicha, MZ; Hökfelt, T; Kopp, UC; Mulder, J; Smith, LA | 1 |
| Bian, JS; Hu, LF; Neo, KL; Pan, TT; Yong, QC | 1 |
| Li, G; Liang, S; Wan, F; Wang, Y; Xu, C; Zhang, A; Zhang, C; Zhu, G | 1 |
| Cicha, MZ; Kopp, UC; Yorek, MA | 1 |
| Angst, MS; Carvalho, B; Clark, DJ | 1 |
| Crawley, B; Fitzsimmons, B; Hua, XY; Malkmus, S; Saito, O; Yaksh, TL | 1 |
| Babu, RJ; Fulzele, SV; Mallampati, R; Patlolla, RR; Singh, M | 1 |
| Benetti, E; Fantozzi, R; Gallicchio, M; Rosa, AC | 1 |
| Cicha, MZ; Grisk, O; Hökfelt, T; Kopp, UC; Mähler, N; Schlüter, T; Smith, LA; Steinbach, A | 1 |
| Abo, M; Fujimura, M; Furusho, S; Katayama, N; Ohkura, N; Tokuda, A | 1 |
| Auer, J; Fischer, MJ; Reeh, PW | 1 |
| Hirata, Y; Hua, XY; Matsui, T; Mizobata, K; Svensson, CI; Yaksh, TL | 1 |
| Cicha, MZ; Jones, SY; Kopp, UC | 1 |
| Back, W; de Grauw, JC; L'ami, JJ; van Dierendonck, M; van Loon, JP; van Weeren, PR | 1 |
| Birklein, F; Fuchs, D; Reeh, PW; Sauer, SK | 1 |
| Angst, MS; Carvalho, B; Clark, DJ; Yeomans, DC | 1 |
| Cicha, MZ; Fritz, N; Hökfelt, T; Kopp, UC; Ruohonen, S; Scheinin, M; Smith, LA | 1 |
| Henry, PJ; Mann, TS; Taylor, SJ | 1 |
| Allen, KA; Bergamasco, L; Coetzee, JF; Dockweiler, J; Edwards-Callaway, LN; Fraccaro, E; Glynn, H; Jones, M; KuKanich, B; Lin, H; Wang, C | 1 |
| Burcham, PC; Cheah, EY; Henry, PJ; Mann, TS | 1 |
| Frallonardo, P; Lorenzin, MG; Oliviero, F; Ortolan, A; Punzi, L; Ramonda, R; Scanu, A | 1 |
| Arruebo, MP; Gonzalo, S; Grasa, L; Martínez de Salinas, F; Murillo, MD; Plaza, MÁ; Valero, MS; Vergara, C | 1 |
| Akiho, H; Ihara, E; Nakamura, K; Tokita, Y; Yamamoto, M | 1 |
| Barbosa, FL; Borges, BS; Brito, HO; Fraga, D; Franco, CRC; Reis, RCD; Zampronio, AR | 1 |
| Heikkilä, HM; Hielm-Björkman, AK; Innes, JF; Laitinen-Vapaavuori, OM | 1 |
| Cheng, G; Hu, S; Ke, D; Wang, Y; Xia, W; Zhou, F; Zhu, C | 1 |
| Eitsuka, T; Handa, O; Ikekawa, N; Inanami, O; Konishi, T; Naito, Y; Narayan Bhilwade, H; Nishida, H; Nishida, M; Tatewaki, N; Yasui, H | 1 |
| He, J; Zheng, S | 1 |
| Chang, S; Chen, Z; Jing, B; Li, X; Shi, H; Zhang, D; Zhao, G; Zheng, Y | 1 |
| Chen, B; Hong, ZF; Liu, H; Liu, J; Xiu, ZB; Zhang, LZ; Zhao, HJ | 1 |
| Ding, N; Ge, N; Liu, H; Liu, J; Liu, L; Wang, H; Wang, S; Wen, J; Zhang, X; Zhao, M | 1 |
4 review(s) available for substance p and dinoprostone
| Article | Year |
|---|---|
Pharmacology of peripheral neuropeptide and inflammatory mediator release.
Topics: Bradykinin; Calcitonin Gene-Related Peptide; Dental Pulp; Dinoprostone; Humans; Inflammation Mediators; Leukotriene B4; Microdialysis; Neuropeptides; Nociceptors; Pulpitis; Substance P; Toothache | 1994 |
Physiology of meningeal innervation: aspects and consequences of chemosensitivity of meningeal nociceptors.
Topics: Afferent Pathways; Animals; Bradykinin; Calcitonin Gene-Related Peptide; Dinoprostone; Disease Models, Animal; Headache; Humans; Meninges; Neurokinin A; Neuropeptides; Nociceptors; Prostaglandins; Substance P | 2001 |
Neuroendocrine, immune, and local responses related to temporomandibular disorders.
Topics: Arthritis; Calcitonin Gene-Related Peptide; Dinoprostone; Facial Pain; Fibromyalgia; Humans; Hyperalgesia; Inflammation Mediators; Interleukin-1; Leukotriene B4; Masseter Muscle; Neuroimmunomodulation; Neuropeptide Y; Neuropeptides; Neurosecretory Systems; Open Bite; Serotonin; Substance P; Synovial Fluid; Temporomandibular Joint Disorders; Tumor Necrosis Factor-alpha | 2001 |
Pain and microcrystalline arthritis.
Topics: Animals; Arthritis, Gouty; Calcium Pyrophosphate; Chronic Pain; Crystallization; Dinoprostone; Disease Models, Animal; Humans; Inflammation Mediators; Interleukin-1beta; Kinins; Musculoskeletal Pain; Nociceptors; Osteoarthritis; Quality of Life; Rats; Substance P; TRPV Cation Channels; Uric Acid | 2014 |
9 trial(s) available for substance p and dinoprostone
| Article | Year |
|---|---|
Potent vasodilator activity of calcitonin gene-related peptide in human skin.
Topics: Adult; Calcitonin Gene-Related Peptide; Dinoprostone; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists; Humans; Male; Neuropeptides; Prostaglandins E; Regional Blood Flow; Skin; Substance P; Vasoactive Intestinal Peptide; Vasodilator Agents | 1986 |
Chronopharmacology of enalapril in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cough; Dinoprostone; Enalapril; Enalaprilat; Female; Half-Life; Humans; Hypertension; Male; Middle Aged; Substance P | 1995 |
The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Topics: Administration, Topical; Adult; Antipruritics; Dermatitis, Atopic; Dinoprostone; Double-Blind Method; Doxepin; Female; Histamine Antagonists; Histamine H1 Antagonists; Humans; Substance P; Terfenadine; Urticaria | 1997 |
Release of algesic substances in human experimental muscle pain.
Topics: Adult; Arm; Dinoprostone; Exercise; Female; Glutamic Acid; Humans; Hypertonic Solutions; Inflammation; Lactic Acid; Leg; Male; Microdialysis; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Nitric Oxide; Pain; Pain Measurement; Sodium Chloride; Substance P; Time Factors | 2002 |
Composition changes in gingival crevicular fluid during orthodontic tooth movement: comparisons between tension and compression sides.
Topics: Adolescent; Child; Dinoprostone; Epidemiologic Methods; Female; Gingival Crevicular Fluid; Humans; Interleukin-1beta; Male; Molar; Peptide Fragments; Stress, Mechanical; Substance P; Tooth Movement Techniques | 2006 |
Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery.
Topics: Biomarkers; Cesarean Section; Chemokine CCL2; Cytokines; Dinoprostone; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunoassay; Inflammation Mediators; Interleukin-10; Interleukin-1beta; Interleukin-6; Interleukin-8; Macrophage Inflammatory Proteins; Nerve Growth Factor; Pregnancy; Prospective Studies; Substance P; Time Factors; Tumor Necrosis Factor-alpha; Wound Healing | 2008 |
Intra-articular opioid analgesia is effective in reducing pain and inflammation in an equine LPS induced synovitis model.
Topics: Analgesics, Opioid; Animals; Bradykinin; Cross-Over Studies; Dinoprostone; Female; Horse Diseases; Horses; Inflammation; Injections, Intra-Articular; Lipopolysaccharides; Morphine; Pain; Proteins; Substance P; Synovial Fluid; Synovitis | 2010 |
Continuous subcutaneous instillation of bupivacaine compared to saline reduces interleukin 10 and increases substance P in surgical wounds after cesarean delivery.
Topics: Adult; Analgesia, Obstetrical; Anesthetics, Local; Bupivacaine; California; Cesarean Section; Dinoprostone; Down-Regulation; Elective Surgical Procedures; Enzyme-Linked Immunosorbent Assay; Exudates and Transudates; Female; Humans; Inflammation Mediators; Infusions, Subcutaneous; Interleukin-10; Nerve Growth Factor; Pain Measurement; Pain, Postoperative; Pregnancy; Sodium Chloride; Subcutaneous Tissue; Substance P; Time Factors; Treatment Outcome; Up-Regulation | 2010 |
The effect of intra-articular botulinum toxin A on substance P, prostaglandin E
Topics: Animals; Arthralgia; Botulinum Toxins, Type A; Dinoprostone; Dog Diseases; Dogs; Double-Blind Method; Female; Injections, Intra-Articular; Male; Osteoarthritis; Pain; Pain Management; Substance P; Synovial Fluid; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
155 other study(ies) available for substance p and dinoprostone
| Article | Year |
|---|---|
Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Binding Sites; Biological Factors; Dinoprost; Dinoprostone; Epithelium; Indomethacin; Male; Muscle Relaxation; Neurokinin B; p-Methoxy-N-methylphenethylamine; Rats; Rats, Wistar; Receptors, Neurokinin-2; Receptors, Neurotransmitter; Substance P; Thromboxane B2; Time Factors; Trachea | 1992 |
Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins.
Topics: Animals; Dinoprostone; Dose-Response Relationship, Drug; Glucuronidase; Guinea Pigs; Macrophages, Alveolar; Male; N-Formylmethionine Leucyl-Phenylalanine; Neurokinin A; Ovalbumin; Peptide Fragments; Receptors, Neurotransmitter; Receptors, Tachykinin; Substance P; Superoxides; Tachykinins; Thromboxane B2 | 1992 |
Effects of trigeminal neurotransmitters on piglet pial arterioles.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Arterioles; Brain; Calcitonin Gene-Related Peptide; Dinoprostone; Indomethacin; Neurokinin A; Nitric Oxide; omega-N-Methylarginine; Pia Mater; Substance P; Swine; Trigeminal Nerve | 1992 |
Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin.
Topics: Adult; Axons; Bradykinin; Capsaicin; Dinoprostone; Dose-Response Relationship, Drug; Humans; Indomethacin; Inflammation; Lidocaine; Middle Aged; p-Methoxy-N-methylphenethylamine; Pyrilamine; Skin; Substance P; Tachyphylaxis; Time Factors; Vasodilation | 1992 |
Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons.
Topics: Animals; Arachidonic Acid; Calcium; Cells, Cultured; Chick Embryo; Dinoprost; Dinoprostone; Electric Conductivity; Leukotriene B4; Neurons, Afferent; Substance P | 1992 |
[Cough as a side effect of angiotensin-converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bronchial Hyperreactivity; Cough; Dinoprostone; Humans; Substance P | 1992 |
Neurokinin inhibition of cholinergic myenteric neurons in canine antrum.
Topics: Acetylcholine; Animals; Atropine; Dinoprostone; Dogs; Electric Stimulation; Enkephalin, Methionine; Female; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth; Myenteric Plexus; Naloxone; Neurokinin A; Neurons; Nifedipine; Phentolamine; Propranolol; Pyloric Antrum; Substance P; Tetrodotoxin; Vasoactive Intestinal Peptide | 1990 |
Endotoxin-induced uveitis (EIU) in the rat: a study of inflammatory and immunological mechanisms.
Topics: Animals; Aqueous Humor; Bacterial Toxins; Cell Count; Ciliary Body; Dinoprostone; Endotoxins; Enterotoxins; Eye Proteins; Histocompatibility Antigens Class II; Inflammation; Leukotriene B4; Male; Rats; Rats, Inbred Lew; Substance P; Thromboxane B2; Uveitis | 1990 |
Detrusor hyperreflexia induced by intravesical instillation of xylene in conscious rats.
Topics: Acetylcholine; Animals; Cystitis; Dinoprostone; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred Strains; Reflex; Substance P; Urinary Bladder; Xylenes | 1990 |
Increased intra-articular substance P and prostaglandin E2 following injection of interleukin-1 in rabbits.
Topics: Animals; Arthritis; Dinoprostone; Interleukin-1; Joints; Rabbits; Substance P; Therapeutic Irrigation | 1990 |
Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: involvement of endothelium-derived relaxing factor.
Topics: Adenosine Diphosphate; Animals; Collagen; Dinoprostone; Guinea Pigs; Hemoglobins; In Vitro Techniques; Male; Nitric Oxide; Platelet Aggregation; Substance P | 1990 |
Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism.
Topics: Animals; Animals, Newborn; Astrocytes; Calcimycin; Cells, Cultured; Cerebellum; Cerebral Cortex; Dinoprostone; Indomethacin; Kinetics; Phosphatidylinositols; Prostaglandin D2; Prostaglandins; Rats; Spinal Cord; Substance P | 1991 |
Responses of human dermal microvascular endothelial cells to histamine and their modulation by interleukin 1 and substance P.
Topics: Dinoprostone; Endothelium; Histamine Release; Humans; Interleukin-1; Microcirculation; Recombinant Proteins; Skin; Substance P | 1991 |
Responses of porcine gastric and duodenal smooth muscle to VIP.
Topics: Acetylcholine; Animals; Bombesin; Bradykinin; Dinoprostone; Duodenum; Electric Stimulation; Gastrointestinal Motility; In Vitro Techniques; Muscle, Smooth; Serotonin; Stomach; Substance P; Swine; Vasoactive Intestinal Peptide | 1991 |
Effects of indomethacin, triamcinolone, and dexamethasone on recombinant human interleukin-1-induced substance P and prostaglandin E2 levels in rabbit knee joints.
Topics: Animals; Cartilage, Articular; Dexamethasone; Dinoprostone; Hindlimb; Indomethacin; Injections, Intra-Articular; Interleukin-1; Iodine Radioisotopes; Joints; Leukocyte Count; Proteoglycans; Rabbits; Radioimmunoassay; Recombinant Proteins; Substance P; Synovial Fluid; Triamcinolone | 1991 |
Nerve-induced tachykinin-mediated vasodilation in skeletal muscle is dependent on nitric oxide formation.
Topics: Animals; Arginine; Atropine; Bradykinin; Calcitonin Gene-Related Peptide; Dinoprostone; Dose-Response Relationship, Drug; Electric Stimulation; Hindlimb; Hyperemia; Muscles; Neurokinin A; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pancuronium; Rabbits; Substance P; Tachykinins; Vasodilation | 1991 |
Evidence for the existence of substance P in the prepubertal rat ovary. I. Biochemical and physiologic studies.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Dinoprostone; Estradiol; Female; Ovary; Prostaglandins E; Radioimmunoassay; Rats; Substance P | 1985 |
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capillary Permeability; Complement C5; Complement C5a, des-Arginine; Dinoprostone; Drug Synergism; Edema; Histamine; Inflammation; Injections, Intradermal; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Nerve Tissue Proteins; Platelet Activating Factor; Prostaglandins E; Rabbits; Rats; Rats, Inbred Lew; Skin; Species Specificity; Substance P | 1985 |
Effects of peptide hormones in urate crystal inflammation.
Topics: Animals; beta-Endorphin; Calcitonin; Dinoprostone; Endorphins; Fatty Acids, Essential; Inflammation; Male; Melanocyte-Stimulating Hormones; Neurotensin; Peptides; Prostaglandins E; Rats; Rats, Inbred Strains; Somatostatin; Substance P; Uric Acid | 1985 |
Effects of substance P on inositol triphosphate accumulation, on contractile responses and on arachidonic acid release and prostaglandin biosynthesis in rabbit iris sphincter muscle.
Topics: Animals; Arachidonic Acids; Diglycerides; Dinoprostone; Dose-Response Relationship, Drug; Female; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Iris; Male; Muscle Contraction; Muscle, Smooth; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Phospholipids; Prostaglandins E; Prostaglandins F; Rabbits; Substance P | 1986 |
Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis.
Topics: Arthritis, Rheumatoid; Dinoprostone; Humans; In Vitro Techniques; Microbial Collagenase; Prostaglandins E; Substance P; Synovial Membrane | 1987 |
[The effects of prostaglandin E2 and substance P on photocoagulation of the rabbit iris].
Topics: Animals; Aqueous Humor; Dinoprostone; Eye Proteins; Intraocular Pressure; Iris; Light Coagulation; Neuropeptides; Prostaglandins E; Rabbits; Substance P | 1986 |
Effects of prostaglandins and other putative chemical intermediaries on the activity of canine testicular polymodal receptors studied in vitro.
Topics: Animals; Aspirin; Bradykinin; Dinoprostone; Dogs; Epoprostenol; In Vitro Techniques; Male; Nociceptors; Prostaglandins; Prostaglandins E; Saline Solution, Hypertonic; Serotonin; Substance P; Testis | 1987 |
Effects of some neurotransmitters and prostanoids on isolated human intracervical arteries.
Topics: Arteries; Cervix Uteri; Dinoprost; Dinoprostone; Epoprostenol; Female; In Vitro Techniques; Neurotransmitter Agents; Norepinephrine; Potassium; Prostaglandins; Prostaglandins E; Prostaglandins F; Substance P; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation | 1988 |
Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Autacoids; Blood Pressure; Body Weight; Bradykinin; Dinoprostone; Injections, Subcutaneous; Lung; Lung Diseases; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Substance P; Time Factors | 1988 |
Endotoxin-induced uveitis in the rat. A study of the role of inflammation mediators.
Topics: Animals; Aqueous Humor; Dinoprost; Dinoprostone; Endotoxins; Leukotriene B4; Male; Pupil; Rats; Rats, Inbred Lew; Salmonella; Substance P; Thromboxane B2; Uveitis | 1988 |
Preincubation of human synovial cells with IL-1 modulates prostaglandin E2 release in response to bradykinin.
Topics: Adjuvants, Immunologic; Bradykinin; Calcimycin; Cells, Cultured; Dinoprost; Dinoprostone; Humans; Interleukin-1; Kinetics; Neurokinin A; Substance P; Synovial Membrane | 1989 |
Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33-824, beta-endorphin and morphine.
Topics: Adolescent; Adult; beta-Endorphin; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Dinoprostone; Drug Synergism; Endorphins; Enkephalin, Methionine; Female; Histamine; Humans; Indomethacin; Male; Middle Aged; Morphine; Naloxone; Prostaglandins E; Pruritus; Skin; Substance P; Vasoactive Intestinal Peptide | 1982 |
Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells.
Topics: Animals; Animals, Newborn; Bradykinin; Capsaicin; Cell Differentiation; Cells, Cultured; Dinoprostone; Ganglia, Spinal; Neurons; Pain; Prostaglandins E; Rats; Substance P; Trigeminal Nerve | 1983 |
A possible role of substance P in the salivary secretion in rats.
Topics: Animals; Brain Chemistry; Catecholamines; Dinoprost; Dinoprostone; Enkephalin, Leucine; Male; Neurotensin; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Saliva; Salivary Glands; Somatostatin; Substance P; Synaptosomes; Time Factors | 1983 |
Ocular responses evoked by capsaicin and prostaglandin E2 are inhibited by a substance P antagonist.
Topics: Animals; Aqueous Humor; Capsaicin; Dinoprostone; Fatty Acids, Unsaturated; Prostaglandins E; Pupil; Rabbits; Substance P; Tetrodotoxin | 1983 |
Response of urethral smooth muscles to pharmacological agents. II. Noncholinergic, nonadrenergic agonists and antagonists.
Topics: Animals; Autonomic Agents; Bradykinin; Cats; Dinoprost; Dinoprostone; Female; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle, Smooth; Prostaglandins E; Prostaglandins F; Substance P; Urethra | 1983 |
Vasoactive intestinal polypeptide influence on lower urinary tract smooth muscle from human and pig.
Topics: Animals; Carbachol; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Ketoprofen; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Propranolol; Prostaglandins E; Prostaglandins F; Substance P; Swine; Tetrodotoxin; Urethra; Urinary Bladder; Vasoactive Intestinal Peptide | 1984 |
Effects of hormones and cytokines on stimulation of adenylate cyclase and intracellular calcium concentration in human and canine periodontal-ligament fibroblasts.
Topics: Adenylyl Cyclases; Adult; Animals; Calcitonin; Calcitonin Gene-Related Peptide; Calcium; Carrier Proteins; Cells, Cultured; Cyclic AMP; Cyclic AMP Receptor Protein; Cytokines; Dinoprostone; Dogs; Fibroblasts; Hormones; Humans; Interleukin-1; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Periodontal Ligament; Platelet Activating Factor; Proteins; Stimulation, Chemical; Substance P; Transforming Growth Factor beta | 1993 |
Neurotransmitters and second messenger systems in the carotid body.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bethanechol; Bethanechol Compounds; Carotid Body; Catecholamines; Cyclic AMP; Dinoprostone; Dopamine; Female; In Vitro Techniques; Isoproterenol; Kinetics; Male; Neurotransmitter Agents; Rabbits; Second Messenger Systems; Serotonin; Substance P; Tyrosine | 1993 |
GnRH and substance P regulate prostaglandins and sex steroids from reptilian (Podarcis sicula sicula) ovarian follicles and corpora lutea.
Topics: Androgens; Animals; Corpus Luteum; Dinoprost; Dinoprostone; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Lizards; Ovarian Follicle; Ovary; Progesterone; Prostaglandins; Substance P; Vitellogenesis | 1994 |
Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Cells, Cultured; Chromatography, High Pressure Liquid; Dinoprostone; Drug Synergism; Female; Ganglia, Spinal; Indomethacin; Neurons, Afferent; Pregnancy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P | 1994 |
The involvement of sympathetic nerves in plasma extravasation induced by prostaglandin E2 and substance P.
Topics: Amino Acid Sequence; Animals; Blood Pressure; Capillary Permeability; Dinoprostone; Guanethidine; Indomethacin; Male; Molecular Sequence Data; Norepinephrine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Substance P; Sympathetic Nervous System | 1994 |
Regulation of the release of interleukin-6 from human astrocytoma cells.
Topics: Adenylyl Cyclases; Alzheimer Disease; Astrocytoma; Calcium; Cycloheximide; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Glial Fibrillary Acidic Protein; Histamine; Humans; Indomethacin; Inositol Phosphates; Interleukin-1; Interleukin-6; Kinetics; Protein Kinase C; Substance P; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Relationships among GnRH, substance P, prostaglandins, sex steroids and aromatase activity in the brain of the male lizard Podarcis sicula sicula during reproduction.
Topics: Androgens; Animals; Aromatase; Aspirin; Brain; Dinoprost; Dinoprostone; Estradiol; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Lizards; Male; Organ Culture Techniques; Progesterone; Prostaglandins; Reproduction; Substance P | 1994 |
Sensitization of nociceptive C-fibers in zinc-deficient rats.
Topics: Afferent Pathways; Animals; Carbonates; Dinoprostone; Electric Stimulation; Hindlimb; Histamine; Leukotriene B4; Male; Nerve Fibers; Nociceptors; Peripheral Nerves; Rats; Rats, Wistar; Reference Values; Regional Blood Flow; Skin; Substance P; Vasodilation; Zinc; Zinc Compounds | 1995 |
Amphibian oocyte: a model of a possible regulatory mechanism for prostaglandin E2 and prostaglandin F2 alpha synthesis.
Topics: Animals; Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Hydroxyprostaglandin Dehydrogenases; Models, Biological; Oocytes; Salamandridae; Substance P | 1995 |
Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2.
Topics: Animals; Anti-Inflammatory Agents; Bradykinin; Dinoprostone; Freund's Adjuvant; Histamine; Inflammation; Interleukin-2; Leukemia, B-Cell; Lipopolysaccharides; Mice; Mice, Inbred BALB C; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Recombinant Proteins; Substance P | 1993 |
The substance P fragment SP-(7-11) increases prostaglandin E2, intracellular Ca2+ and collagenase production in bovine articular chondrocytes.
Topics: Amino Acid Sequence; Animals; Calcium; Cartilage, Articular; Cattle; Cells, Cultured; Collagenases; Dinoprostone; Molecular Sequence Data; Peptide Fragments; Substance P | 1993 |
Sodium cromoglycate: evidence of tachykinin antagonist activity in the human skin.
Topics: Adult; Autoradiography; Capillary Permeability; Chromatography, Gel; Chromatography, High Pressure Liquid; Cromolyn Sodium; Dinoprostone; Histamine Antagonists; Humans; Injections, Intradermal; Iodine Radioisotopes; Male; Neurokinin B; Skin; Skin Tests; Solvents; Substance P; Succinimides; Tachykinins | 1993 |
Immunohistochemical distribution, biochemical characterization, and biological action of tachykinins in the frog adrenal gland.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenal Cortex Hormones; Adrenal Glands; Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Dinoprostone; Fluorescent Antibody Technique; Immunohistochemistry; Male; Microscopy, Immunoelectron; Molecular Sequence Data; Neurokinin A; Neurokinin B; Rana ridibunda; Substance P; Tachykinins; Tissue Distribution | 1993 |
A role for the C-terminal fragment of substance P,SP7-11 in the pathogenesis of arthritis.
Topics: Amino Acid Sequence; Animals; Arthritis; Cartilage, Articular; Cattle; Collagenases; Dinoprostone; Kinetics; Molecular Sequence Data; Neurokinin A; Neurokinin B; Peptide Fragments; Substance P | 1993 |
Prostaglandin E2 stimulation of acetylcholine release from guinea pig myenteric plexus neurons.
Topics: Acetylcholine; Animals; Calcitonin Gene-Related Peptide; Calcium Channel Blockers; Calcium Channels; Culture Techniques; Cyclic AMP; Dideoxyadenosine; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Guinea Pigs; Male; Myenteric Plexus; Sincalide; Substance P | 1993 |
Altered vascular permeability responses to substance P in diabetic rats: interactions with a nitric oxide synthesis inhibitor.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Glucose; Blood Pressure; Capillary Permeability; Diabetes Mellitus, Experimental; Dinoprostone; Drinking; Injections, Intravenous; Male; Nitric Oxide Synthase; Nitroarginine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Substance P | 1993 |
Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Carrageenan; Clomipramine; Dinoprostone; Dose-Response Relationship, Drug; Edema; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts.
Topics: Animals; Arachidonic Acid; Aspirin; Cattle; Cell Division; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Epidermal Growth Factor; Fibroblast Growth Factors; Fibroblasts; Humans; Leukotriene B4; Prostaglandin-Endoperoxide Synthases; Skin; Substance P | 1996 |
Carbamazepine exerts anti-inflammatory effects in the rat.
Topics: Animals; Anti-Inflammatory Agents; Carbamazepine; Dinoprostone; Dose-Response Relationship, Drug; Edema; Exudates and Transudates; Hyperalgesia; Inflammation; Male; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reaction Time; Substance P | 1995 |
Neural involvement in 5-hydroxytryptamine-induced net electrogenic ion secretion in the rat intestine in-vivo.
Topics: Acetylcholine; Animals; Atropine; Cholinergic Antagonists; Colon; Dinoprostone; Electrophysiology; Hexamethonium; Ileum; Intestinal Mucosa; Intestines; Ion Channels; Jejunum; Male; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Substance P | 1996 |
Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro.
Topics: Action Potentials; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Dinoprostone; Ganglia, Spinal; Immunohistochemistry; Male; Neurons, Afferent; Nociceptors; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Substance P | 1996 |
Mechanism of prostaglandin E2-induced substance P release from cultured sensory neurons.
Topics: Animals; Cells, Cultured; Dinoprostone; Ganglia, Sensory; Ganglia, Spinal; Male; Nifedipine; Radioimmunoassay; Rats; Rats, Wistar; Substance P | 1996 |
Prostaglandin E2 increases the proportion of neonatal rat dorsal root ganglion neurons that respond to bradykinin.
Topics: Animals; Animals, Newborn; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Cell Size; Cells, Cultured; Dinoprostone; Epoprostenol; Ganglia, Spinal; Immunohistochemistry; Neurons; Rats; Rats, Sprague-Dawley; Substance P | 1996 |
Mediation by prostaglandins of the stimulatory effect of substance P on cyclic AMP production in dog iris sphincter smooth muscle.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Iris; Kinetics; Muscle Contraction; Muscle, Smooth; Phospholipases A; Phospholipases A2; Prostaglandins; Quinacrine; Receptors, Prostaglandin; Substance P | 1996 |
Pharmacological activation changes stiffness of cultured human airway smooth muscle cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Actins; Bradykinin; Bronchodilator Agents; Bucladesine; Carbachol; Cells, Cultured; Colforsin; Collagen; Cytoskeleton; Dinoprostone; Histamine; Humans; Isoproterenol; Kinetics; Magnetics; Muscarinic Agonists; Muscle Contraction; Muscle, Smooth; Myosins; Potassium Chloride; Substance P; Time Factors; Trachea | 1996 |
Co-regulation of mucosal prostanoids and substance P by indomethacin in rat stomachs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Dinoprostone; Gastric Mucosa; Indomethacin; Male; Rats; Rats, Sprague-Dawley; Substance P | 1997 |
Cellular mechanism of substance P in the regulation of corticosteroid secretion by newt adrenal gland.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Animals; Corticosterone; Cyclic GMP; Dinoprostone; Models, Molecular; Nitric Oxide Synthase; Substance P; Triturus | 1997 |
Indomethacin influences regulatory peptides and increases DNA synthesis in the gastrointestinal tract of the rat.
Topics: Animals; Calcitonin Gene-Related Peptide; Cell Division; Colon; Digestive System; Dinoprostone; DNA; Gastric Mucosa; Gastrins; Glucagon; Indomethacin; Intestinal Mucosa; Intestine, Small; Neurokinin A; Neuropeptides; Neurotensin; Rats; Rats, Sprague-Dawley; Somatostatin; Stomach; Substance P | 1997 |
Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
Topics: Adrenergic beta-Antagonists; Animals; Benzimidazoles; Bradykinin; Calcium; Cells, Cultured; Chymases; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Gastrointestinal Motility; In Vitro Techniques; Indomethacin; Inflammation Mediators; Leupeptins; Mast Cells; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitroprusside; Rats; Receptor, PAR-2; Receptors, Cell Surface; Serine Endopeptidases; Substance P; Tetrodotoxin; Time Factors; Trypsin; Tryptases | 1997 |
Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production.
Topics: Astrocytes; Cells, Cultured; Cytokines; Dinoprostone; Humans; Interleukin-1; Interleukin-6; Receptors, Neurokinin-1; Spinal Cord; Substance P; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1997 |
Kinetics of peptide-induced release of inflammatory mediators by the urinary bladder.
Topics: Animals; Bradykinin; Cystitis; Dinoprost; Dinoprostone; Female; Guinea Pigs; Histamine; Inflammation Mediators; Leukotriene B4; Peptides; Somatostatin; Substance P | 1997 |
Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints.
Topics: Animals; Blood Pressure; Cartilage, Articular; Denervation; Dinoprostone; Female; Horses; Inflammation; Interleukin-1; Interleukin-6; Joints; Male; Neutrophils; Orchiectomy; Perfusion; Phosphopyruvate Hydratase; Substance P; Synovial Fluid; Synovial Membrane | 1998 |
Effects of prostaglandin E2 on nitric oxide-mediated nonadrenergic noncholinergic relaxations in the guinea-pig tracheal muscle.
Topics: Animals; Autonomic Nervous System; Dinoprostone; Electric Stimulation; Enzyme Inhibitors; Guinea Pigs; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Sodium-Potassium-Exchanging ATPase; Substance P; Trachea | 1998 |
Tachykinins as enhancers of prostaglandin E2-induced intraocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Endophthalmitis; Eye; Eye Proteins; Hyperemia; Indomethacin; Injections; Iris; Male; Miosis; Neurokinin A; Rabbits; Substance P; Tachykinins; Vitreous Body | 1998 |
Tachykinins mediate changes in ion transport in porcine jejunum through release of prostaglandins and neurotransmitters.
Topics: Animals; Dinoprostone; Electrophysiology; Female; Ion Transport; Jejunum; Male; Neurokinin A; Neurotransmitter Agents; Piroxicam; Prostaglandins; Substance P; Swine; Tachykinins; Tetrodotoxin; Vasoactive Intestinal Peptide | 1998 |
Substance P and capsaicin release prostaglandin E2 from rat intrapulmonary bronchi.
Topics: Animals; Bronchi; Capsaicin; Dinoprostone; Epithelial Cells; In Vitro Techniques; Indoles; Isoindoles; Male; Meclofenamic Acid; Models, Biological; Muscle, Smooth; Nerve Fibers; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substance P | 1998 |
Mechanism for substance P-induced relaxation of precontracted airway smooth muscle during development.
Topics: Aging; Animals; Animals, Newborn; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Muscle Development; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Substance P; Trachea | 1999 |
Calcitonin gene-related peptide and prostaglandin E2 but not substance P release induced by antidromic nerve stimulation from rat skin in vitro.
Topics: Acetamides; Analgesics, Opioid; Animals; Calcitonin Gene-Related Peptide; Dinoprostone; Electric Stimulation; Female; In Vitro Techniques; Male; Membrane Potentials; Nerve Fibers; Neurogenic Inflammation; Nociceptors; Pain; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Skin; Stimulation, Chemical; Substance P; Vasodilation | 1999 |
Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids.
Topics: Amino Acids; Analgesics; Animals; Dinoprostone; Hot Temperature; Hyperalgesia; Indoles; Injections, Spinal; Isoindoles; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Rats; Rats, Inbred Strains; Spinal Cord; Substance P | 1999 |
The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia.
Topics: Amitriptyline; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Clonazepam; Dinoprostone; Disease Models, Animal; Hyperalgesia; Indomethacin; Male; Neuralgia; Pain; Pain Threshold; Peripheral Nerve Injuries; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Sciatic Nerve; Seminal Vesicles; Sheep; Substance P | 1999 |
Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro.
Topics: Afferent Pathways; Animals; Arachnoid; Bradykinin; Calcitonin Gene-Related Peptide; Dinoprostone; Dura Mater; Electric Stimulation; Headache; Histamine; Inflammation; Male; Migraine Disorders; Neurons, Afferent; Nociceptors; Organ Culture Techniques; Rats; Rats, Wistar; Serotonin; Substance P; Trigeminal Ganglion; Vasodilation | 1999 |
In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capsaicin; Carrageenan; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Ibuprofen; In Vitro Techniques; Inflammation; Knee Joint; Male; N-Methylaspartate; Prostaglandins; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P; Thromboxane B2 | 1999 |
PGE2 increases substance P release from renal pelvic sensory nerves via activation of N-type calcium channels.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Dinoprostone; Kidney Pelvis; Male; Neurons, Afferent; omega-Conotoxin GVIA; Peptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Substance P; Verapamil | 1999 |
Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bradykinin; Bradykinin Receptor Antagonists; Carrageenan; Dinoprostone; Inflammation Mediators; Injections, Intra-Articular; Knee Joint; Male; Pain; Rats; Rats, Wistar; Stimulation, Chemical; Substance P; Tumor Necrosis Factor-alpha | 1999 |
Activation of renal mechanosensitive neurons involves bradykinin, protein kinase C, PGE(2), and substance P.
Topics: Adrenergic beta-Antagonists; Analgesics; Animals; Antimetabolites; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Indoles; Isoindoles; Kidney; Kidney Pelvis; Male; Mechanoreceptors; Naphthalenes; Natriuresis; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Phorbol 12,13-Dibutyrate; Pressure; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, Bradykinin; Receptors, Neurokinin-1; Substance P | 2000 |
Relationship of the substance P to indicators of host response in human gingival crevicular fluid.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Biomarkers; Chemokine CCL2; Dental Plaque Index; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Gingival Crevicular Fluid; Gingivitis; Humans; Interleukin-1; Interleukin-8; Male; Middle Aged; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxidase; Substance P; Tumor Necrosis Factor-alpha | 2000 |
Concentrations of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints of horses.
Topics: Animals; Dinoprostone; Female; Horse Diseases; Horses; Joint Diseases; Male; Osteoarthritis; Radiography; Radioimmunoassay; Statistics, Nonparametric; Substance P; Synovial Fluid | 2000 |
Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons.
Topics: Action Potentials; Animals; Calcitonin Gene-Related Peptide; Cells, Cultured; Cyclic AMP; Dinoprost; Dinoprostone; F2-Isoprostanes; Female; Isoprostanes; Male; Nerve Fibers; Neurons, Afferent; Pain; Prostaglandins; Rats; Rats, Sprague-Dawley; Reaction Time; Substance P | 2000 |
Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis.
Topics: Acetylcholine; Animals; Colitis; Colon; Dinoprostone; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Interleukin-11; Male; Motilin; Muscle Contraction; Muscle, Smooth; Potassium Chloride; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neurokinin-1; Receptors, Neuropeptide; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substance P; Tensile Strength; Trinitrobenzenesulfonic Acid | 2000 |
Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A.
Topics: Adenylyl Cyclases; Animals; Bradykinin; Bucladesine; Calcium; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Ganglia, Spinal; Inositol 1,4,5-Trisphosphate; Isoquinolines; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Substance P; Sulfonamides; Tritium | 2000 |
Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study.
Topics: Adult; Calcitonin Gene-Related Peptide; Codeine; Dinoprostone; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Female; Histamine Release; Humans; Male; Microdialysis; Neuropeptides; Sensation; Skin; Substance P; Vasoconstrictor Agents; Vasodilation | 2000 |
Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
Topics: Analgesics, Opioid; Animals; Brain; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Indomethacin; Injections, Intraventricular; Injections, Spinal; Male; Mice; Morphine; Nociceptin; Opioid Peptides; Pain Measurement; Receptors, Prostaglandin; Spinal Cord; Substance P | 2001 |
Antinociceptive effect induced by intraperitoneal administration of vitamin K2 (menatetrenone) in ICR mice.
Topics: Analgesics; Animals; Behavior, Animal; Bradykinin; Dinoprostone; Injections, Intraperitoneal; Injections, Spinal; Male; Mice; Mice, Inbred ICR; N-Methylaspartate; Substance P; Vitamin K; Vitamin K 2 | 2000 |
Chloride channel function is linked to epithelium-dependent airway relaxation.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Triphosphate; Animals; Bronchoconstriction; Calcium Channel Blockers; Chloride Channels; Dinoprostone; Dose-Response Relationship, Drug; Gluconates; In Vitro Techniques; Isometric Contraction; Mice; Mice, Inbred CFTR; Muscle Relaxation; Nitrobenzoates; ortho-Aminobenzoates; Perfusion; Reproducibility of Results; Respiratory Mucosa; Stilbenes; Substance P; Trachea | 2001 |
Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Cyclooxygenase Inhibitors; Dinoprostone; Drug Combinations; Female; Flurbiprofen; Histamine; Hydrogen-Ion Concentration; In Vitro Techniques; Inflammation Mediators; Male; Nociceptors; Rats; Rats, Wistar; Serotonin; Skin; Substance P | 2001 |
Changes in paw oedema triggered via bradykinin B(1) and B(2) receptors in streptozotocin-diabetic rats.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Dinoprostone; Edema; Hindlimb; Hypoglycemic Agents; Insulin, Long-Acting; Male; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Substance P; Time Factors | 2001 |
Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice.
Topics: Animals; Arginine; Bronchoconstriction; Cystic Fibrosis; Dinoprostone; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; In Vitro Techniques; Male; Mice; Mice, Inbred CFTR; Muscle Relaxation; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Substance P; Trachea | 2001 |
EP2 receptors mediate airway relaxation to substance P, ATP, and PGE2.
Topics: Acetylcholine; Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Dinoprostone; Isoproterenol; Mice; Mice, Knockout; Muscle Relaxation; Muscle, Smooth; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Substance P; Trachea | 2001 |
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Ibuprofen; Injections, Intraperitoneal; Injections, Spinal; Isoenzymes; Male; Membrane Proteins; N-Methylaspartate; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2001 |
Substance P, calcitonin gene related peptide and PGE2 co-released from the mouse colon: a new model to study nociceptive and inflammatory responses in viscera, in vitro.
Topics: Animals; Calcitonin Gene-Related Peptide; Colon; Dinoprostone; Female; Hot Temperature; Inflammation; Male; Mice; Pain Measurement; Substance P; Viscera | 2001 |
Prostaglandin E(2) inhibits fibroblast chemotaxis.
Topics: Adrenergic beta-Agonists; Animals; Bronchi; Bucladesine; Cattle; Cell Line; Chemotactic Factors; Chemotaxis; Colforsin; Culture Media, Conditioned; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Fetus; Fibroblasts; Fibronectins; Humans; Indomethacin; Isoproterenol; Oxytocics; Respiratory Mucosa; Substance P; Vasoactive Intestinal Peptide; Vasodilator Agents | 2001 |
Endogenous angiotensin modulates PGE(2)-mediated release of substance P from renal mechanosensory nerve fibers.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dinoprostone; In Vitro Techniques; Kidney; Losartan; Male; Mechanoreceptors; Nerve Fibers; Neurons, Afferent; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sodium, Dietary; Substance P; Vasoconstrictor Agents | 2002 |
Topical diclofenac sodium decreases the substance P content of tears.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Eye Proteins; Female; Humans; Immunoenzyme Techniques; Male; Ophthalmic Solutions; Substance P; Tears | 2002 |
Inhibitory effects of azelastine on substance P-induced itch-associated response in mice.
Topics: Animals; Anti-Allergic Agents; Behavior, Animal; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Histamine; Histamine H1 Antagonists; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Neutrophils; Phthalazines; Pruritus; Skin; Substance P | 2002 |
Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Enzyme Inhibitors; Glucocorticoids; Immunosuppressive Agents; Indomethacin; Keratinocytes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mast Cells; Mice; Mice, Inbred ICR; Mice, Mutant Strains; Phenylpropionates; Phospholipases A; Pruritus; Receptors, Leukotriene B4; Receptors, Neurokinin-1; Substance P | 2001 |
In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bromelains; Carrageenan; Dinoprostone; Exudates and Transudates; Inflammation; Male; Rats; Rats, Sprague-Dawley; Substance P | 2002 |
Twenty-four hour exposure to prostaglandin downregulates prostanoid receptor binding but does not alter PGE(2)-mediated sensitization of rat sensory neurons.
Topics: Animals; Cells, Cultured; Cyclic AMP; Dinoprostone; Down-Regulation; Female; Ganglia, Spinal; Male; Neurogenic Inflammation; Neurons, Afferent; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Spinal Cord; Substance P; Tritium | 2002 |
PGE(2) increases release of substance P from renal sensory nerves by activating the cAMP-PKA transduction cascade.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Bradykinin; Calcitonin Gene-Related Peptide; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; In Vitro Techniques; Kidney Pelvis; Male; Neurons, Afferent; Peripheral Nerves; Pressure; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance P | 2002 |
Substance P-evoked Cl(-) secretion in guinea pig distal colonic epithelia: interaction with PGE(2).
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Calcium; Chlorides; Colforsin; Colon; Dinoprostone; Drug Synergism; Electric Conductivity; Evoked Potentials; Guinea Pigs; In Vitro Techniques; Intestinal Mucosa; Male; Piroxicam; Substance P; Tetrodotoxin | 2002 |
Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint.
Topics: Adolescent; Adult; Aged; Arthralgia; Bradykinin; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Facial Pain; Female; Humans; Inflammation Mediators; Joint Dislocations; Leukotriene B4; Male; Middle Aged; Neurotransmitter Agents; Nociceptors; Osteoarthritis; Serotonin; Statistics, Nonparametric; Substance P; Synovial Fluid; Synovitis; Temporomandibular Joint Disorders | 2002 |
Interleukin-1beta expression on ovarian granulosa cells and its clinical implication in women undergoing in vitro fertilization.
Topics: Adult; Dinoprostone; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Granulosa Cells; Humans; Infertility, Female; Interleukin-1; Luteinizing Hormone; Male; Substance P | 2002 |
Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dinoprostone; Heart Failure; Kidney; Losartan; Male; Models, Animal; Natriuresis; Neurons, Afferent; Pressure; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sodium; Sodium, Dietary; Substance P | 2003 |
Substance P and prostaglandin E2 release after shock wave application to the rabbit femur.
Topics: Analysis of Variance; Animals; Dinoprostone; Female; Femur; Lithotripsy; Rabbits; Substance P | 2003 |
Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP.
Topics: Angiotensin II; Animals; Bradykinin; Cyclic AMP; Diet; Dinoprostone; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney Pelvis; Neurons, Afferent; Pertussis Toxin; Rats; Signal Transduction; Sodium; Substance P | 2003 |
Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Kidney Pelvis; Losartan; Neurons, Afferent; Osmolar Concentration; Pertussis Toxin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P | 2004 |
Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Calcitonin Gene-Related Peptide; Capillary Permeability; Celecoxib; Cyclooxygenase Inhibitors; Dental Pulp; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Leukocytes; Lipopolysaccharides; Male; Pulpitis; Pyrazoles; Rats; Skin; Substance P; Sulfonamides | 2004 |
Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia.
Topics: Adjuvants, Immunologic; Animals; Borrelia burgdorferi; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Enzyme Induction; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Microglia; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Receptors, Neurokinin-1; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; Substance P; Up-Regulation | 2004 |
Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
Topics: Afferent Pathways; Alprostadil; Animals; Calcitonin Gene-Related Peptide; Cyclic AMP; Cyclooxygenase 2; Dinoprostone; Fluorescent Antibody Technique; Ganglia, Spinal; Immunohistochemistry; Isoenzymes; Kidney; Male; Prostaglandin-Endoperoxide Synthases; Prostaglandins E, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Substance P | 2004 |
Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome.
Topics: Adult; Blotting, Western; Calcitonin Gene-Related Peptide; Dinoprostone; Female; Humans; Immunoassay; Interleukin-1; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2004 |
Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2.
Topics: Animals; Blotting, Western; Carrageenan; Dialysis; Dinoprostone; Dose-Response Relationship, Drug; Functional Laterality; Gene Expression Regulation, Enzymologic; Group II Phospholipases A2; Hyperalgesia; Indoles; Inflammation; Inhibition, Psychological; Male; Pain Measurement; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Reaction Time; Spinal Cord; Substance P; Time Factors | 2005 |
Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Budesonide; Cyclooxygenase 2; Cytokines; Diarrhea; Dinoprostone; Disease Models, Animal; Humans; Irritable Bowel Syndrome; Lymphocyte Activation; Membrane Proteins; Mice; Models, Biological; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Substance P; T-Lymphocytes; Trichinella spiralis; Trichinellosis | 2005 |
Mechanisms of antinociception of spinal galanin: how does galanin inhibit spinal sensitization?
Topics: Animals; Carrageenan; Dinoprostone; Galanin; Hyperalgesia; Injections, Spinal; Male; Nociceptors; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Spinal Cord; Substance P | 2005 |
Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release.
Topics: Animals; Carrageenan; Chemical Phenomena; Chemistry, Physical; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Injections, Intraperitoneal; Injections, Spinal; Male; Microdialysis; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Spinal Cord; Substance P | 2006 |
Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Benzamides; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Endothelial Cells; Flavonoids; Furans; Gene Expression Regulation; Humans; Imidazoles; MAP Kinase Signaling System; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurokinin-1 Receptor Antagonists; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Pyridines; Quinuclidines; Receptors, Neurokinin-1; Receptors, Neurokinin-2; RNA, Messenger; Substance P; Time Factors; Umbilical Veins | 2006 |
Prostaglandin involvement in lung C-fiber activation by substance P in guinea pigs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Asthma; Blood Pressure; Bradykinin; Capsaicin; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Guinea Pigs; Heart Rate; Indomethacin; Lung; Nerve Fibers, Unmyelinated; Prostaglandins; Respiratory Hypersensitivity; Substance P | 2006 |
Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.
Topics: Animals; Base Sequence; Binding Sites; Cell Line; Colon; Cyclooxygenase 2; Dinoprostone; DNA; Epithelial Cells; Humans; Janus Kinase 2; Male; Mice; Mice, Inbred C57BL; Mutagenesis, Site-Directed; Neurokinin-1 Receptor Antagonists; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Neurokinin-1; Signal Transduction; STAT Transcription Factors; STAT3 Transcription Factor; STAT5 Transcription Factor; Substance P | 2006 |
Substance P stimulates release of RANKL via COX-2 expression in human dental pulp cells.
Topics: Adolescent; Adult; Carrier Proteins; Cell Line; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dental Pulp; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Male; Membrane Glycoproteins; Membrane Proteins; Nitrobenzenes; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Substance P; Sulfonamides | 2006 |
Pain discomfort and crevicular fluid changes induced by orthodontic elastic separators in children.
Topics: Adolescent; Case-Control Studies; Child; Dinoprostone; Female; Gingival Crevicular Fluid; Humans; Interleukin-1; Male; Orthodontic Appliances; Pain; Pain Measurement; Substance P; Tooth Movement Techniques | 2006 |
Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations.
Topics: Alprostadil; Animals; Benzyl Compounds; Blood Platelets; Dinoprostone; Endothelium, Vascular; Enzyme Inhibitors; Guinea Pigs; Humans; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Protein Binding; Rabbits; Receptors, Epoprostenol; Substance P | 2006 |
Activation of endothelin-a receptors contributes to angiotensin-induced suppression of renal sensory nerve activation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Endothelin A Receptor Antagonists; Kidney; Kidney Pelvis; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Peptides, Cyclic; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium, Dietary; Substance P | 2007 |
Prognostic factors in arthrocentesis of the temporomandibular joint: Comparison of bradykinin, leukotriene B4, prostaglandin E2, and substance P level in synovial fluid between successful and unsuccessful cases.
Topics: Adolescent; Adult; Aged; Bradykinin; Dinoprostone; Female; Humans; Joint Dislocations; Leukotriene B4; Male; Middle Aged; Osteoarthritis; Pain; Paracentesis; Prognosis; Statistics, Nonparametric; Substance P; Synovial Fluid; Temporomandibular Joint Disorders | 2007 |
Cyclic AMP signaling contributes to neural plasticity and hyperexcitability in AH sensory neurons following intestinal Trichinella spiralis-induced inflammation.
Topics: Animals; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Dideoxyadenosine; Dinoprostone; Guinea Pigs; Histamine; Imidazoles; In Vitro Techniques; Intestinal Mucosa; Leukotriene B4; Lysine; Male; Membrane Potentials; Muscle, Smooth; Neuronal Plasticity; Neurons, Afferent; Nitric Oxide; Peroxidase; Signal Transduction; Substance P; Thiobarbituric Acid Reactive Substances; Trichinella spiralis; Trichinellosis; Tryptases | 2007 |
Substance P augments PGE2 and IL-6 production in titanium particles-stimulated fibroblasts from hip periprosthetic membrane.
Topics: Aged; Dinoprostone; Female; Fibroblasts; Hip Prosthesis; Humans; Interleukin-6; Male; Membranes; Substance P; Titanium | 2007 |
Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals.
Topics: Administration, Cutaneous; Animals; Biomarkers; Calcitonin Gene-Related Peptide; Dermatitis, Irritant; Dinoprostone; Hydrocarbons; Irritants; Microdialysis; Rats; Rats, Inbred Strains; Skin; Skin Irritancy Tests; Substance P; Xylenes | 2007 |
Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cytokines; Dinoprostone; Diphosphonates; Drug Evaluation, Preclinical; Edema; Foot; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Ibandronic Acid; Inflammation; Interleukin-1beta; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tumor Necrosis Factor-alpha | 2008 |
Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Fibers; Animals; Calcitonin Gene-Related Peptide; Dinoprostone; Indomethacin; Kidney; Male; Neurons, Afferent; Neurons, Efferent; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Substance P; Thiophenes; Triazoles | 2007 |
Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes.
Topics: Air Pollutants; Animals; Blotting, Western; Cell Separation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Inhibitors; Heart Diseases; Hydrogen Sulfide; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Janus Kinases; KATP Channels; Male; Myocardial Contraction; Myocytes, Cardiac; Protective Agents; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance P | 2008 |
Myocardial ischemic nociceptive signaling mediated by P2X3 receptor in rat stellate ganglion neurons.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Dinoprostone; Drug Interactions; Electric Stimulation; Female; Gene Expression Regulation; Male; Membrane Potentials; Myocardial Ischemia; Neuralgia; Neurons; Patch-Clamp Techniques; Phenols; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Signal Transduction; Stellate Ganglion; Substance P | 2008 |
Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Baroreflex; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Kidney; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Substance P | 2008 |
Acetaminophen prevents hyperalgesia in central pain cascade.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Animals; Dinoprostone; Hyperalgesia; Injections, Spinal; Male; Neurotransmitter Agents; Pain; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2008 |
Dermal microdialysis of inflammatory markers induced by aliphatic hydrocarbons in rats.
Topics: alpha-MSH; Animals; Biomarkers; Dermatitis, Irritant; Dinoprostone; Hydrocarbons; Interleukin-6; Microdialysis; Rats; Rats, Hairless; Skin; Structure-Activity Relationship; Substance P | 2009 |
Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.
Topics: Blotting, Western; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Ligands; Mitogen-Activated Protein Kinases; Neutrophils; NF-kappa B; Phosphorylation; Polymerase Chain Reaction; Receptors, Tachykinin; Substance P | 2009 |
Dietary sodium modulates the interaction between efferent renal sympathetic nerve activity and afferent renal nerve activity: role of endothelin.
Topics: Afferent Pathways; Animals; Antihypertensive Agents; Blood Pressure; Dinoprostone; Efferent Pathways; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Ganglia, Spinal; Gene Expression; Kidney; Kidney Pelvis; Male; Models, Biological; Myocytes, Smooth Muscle; Neuroglia; Norepinephrine; Oligopeptides; Peptides, Cyclic; Physical Stimulation; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Reflex; Sodium, Dietary; Substance P | 2009 |
Effects of macrolides on antigen-induced increases in cough reflex sensitivity in guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Antigens; Bronchoalveolar Lavage Fluid; Cough; Dinoprostone; Erythromycin; Guinea Pigs; Leukotriene B4; Macrolides; Male; Reflex; Substance P | 2010 |
Acid-induced CGRP release from the stomach does not depend on TRPV1 or ASIC3.
Topics: Acid Sensing Ion Channels; Acids; Amiloride; Animals; Calcitonin Gene-Related Peptide; Data Interpretation, Statistical; Dinoprostone; Gastric Mucosa; Hydrogen-Ion Concentration; Immunoenzyme Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Sodium Channels; Stomach; Substance P; TRPV Cation Channels | 2010 |
Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase.
Topics: Animals; Animals, Newborn; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Lipopolysaccharides; Membrane Proteins; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Signal Transduction; Spinal Cord; Substance P; Time Factors; Toll-Like Receptor 4 | 2010 |
Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure.
Topics: Afferent Pathways; Animals; Antihypertensive Agents; Dinoprostone; Disease Models, Animal; Endothelin A Receptor Antagonists; Heart Failure; Hydrostatic Pressure; Kidney; Kidney Pelvis; Male; Mechanoreceptors; Myocardium; Organ Size; Peptides, Cyclic; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium; Substance P; Ventricular Dysfunction, Left | 2010 |
Sensitized peripheral nociception in experimental diabetes of the rat.
Topics: Action Potentials; Animals; Behavior, Animal; Bradykinin; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; In Vitro Techniques; Male; Nerve Fibers; Nociceptors; Pain Measurement; Pain Threshold; Rats; Reaction Time; Sciatic Nerve; Skin; Streptozocin; Substance P | 2010 |
Dietary sodium modulates the interaction between efferent and afferent renal nerve activity by altering activation of α2-adrenoceptors on renal sensory nerves.
Topics: Adrenergic alpha-2 Receptor Antagonists; Afferent Pathways; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Dinoprostone; Efferent Pathways; Heart Rate; Hot Temperature; Kidney; Kidney Pelvis; Male; Norepinephrine; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sensory Receptor Cells; Sodium, Dietary; Substance P | 2011 |
Impaired interaction between efferent and afferent renal nerve activity in SHR involves increased activation of alpha2-adrenoceptors.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Kidney; Losartan; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-2; Substance P; Sympathetic Nervous System | 2011 |
Influence of influenza A infection on capsaicin-induced responses in murine airways.
Topics: Animals; Biphenyl Compounds; Bronchoalveolar Lavage Fluid; Capsaicin; Carbachol; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Inflammation; Influenza A virus; Isoproterenol; Leukocytes; Male; Mice; Mice, Inbred BALB C; Models, Biological; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Orthomyxoviridae Infections; Piperidines; Prostaglandin Antagonists; Respiratory Mucosa; Specific Pathogen-Free Organisms; Substance P; Trachea; TRPV Cation Channels; Xanthones | 2012 |
The effect of timing of oral meloxicam administration on physiological responses in calves after cautery dehorning with local anesthesia.
Topics: Administration, Oral; Anesthesia, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Dairying; Dinoprostone; Haptoglobins; Horns; Hydrocortisone; Male; Meloxicam; Pain Measurement; Substance P; Thiazines; Thiazoles | 2013 |
Acrolein relaxes mouse isolated tracheal smooth muscle via a TRPA1-dependent mechanism.
Topics: Acrolein; Animals; Dinoprostone; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Muscle, Smooth; Substance P; Trachea; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2014 |
Roles of Toll-Like Receptor 4, IκB Kinase, and the Proteasome in the Intestinal Alterations Caused by Sepsis.
Topics: Acetylcholine; Animals; Cell-Penetrating Peptides; Cytokines; Dinoprostone; Disease Models, Animal; Duodenum; Endotoxins; Gastrointestinal Motility; Gene Expression Regulation; I-kappa B Kinase; Inflammation Mediators; Leupeptins; Male; Muscle Contraction; Neomycin; Polymyxin B; Potassium Chloride; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinase Inhibitors; Rabbits; Sepsis; Signal Transduction; Substance P; Toll-Like Receptor 4 | 2015 |
Contraction of gut smooth muscle cells assessed by fluorescence imaging.
Topics: Animals; Cell Separation; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Drug Discovery; Fatty Acids, Unsaturated; Gastrointestinal Motility; Histamine; Intestine, Small; Male; Mice, Inbred BALB C; Muscle Contraction; Muscle, Smooth; Optical Imaging; Panax; Plant Extracts; Polyunsaturated Alkamides; Serotonin; Stimulation, Chemical; Substance P; Zanthoxylum; Zingiberaceae | 2015 |
Evidence of substance P autocrine circuitry that involves TNF-α, IL-6, and PGE2 in endogenous pyrogen-induced fever.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Corticotropin-Releasing Hormone; Dinoprostone; Fever; Gene Expression Regulation; Hypothalamus; Indomethacin; Interleukin-6; Male; Morphine; Polysaccharides; Pyrogens; Rats; Rats, Wistar; Receptors, Neurokinin-1; Substance P; Time Factors; Tropanes; Tumor Necrosis Factor-alpha | 2016 |
Antifertility effectiveness of a novel copper-containing intrauterine device material and its influence on the endometrial environment in rats.
Topics: Animals; Contraceptive Agents; Copper; Dinoprostone; Endometrium; Female; Fertility; Intrauterine Devices, Copper; Matrix Metalloproteinase 9; Microscopy, Electron, Scanning; Pregnancy; Rats; Silicone Elastomers; Spectrometry, X-Ray Emission; Substance P; Surface Properties; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A | 2018 |
The Adjuvant Effect of Squalene, an Active Ingredient of Functional Foods, on Doxorubicin-Treated Allograft Mice.
Topics: Allografts; Analgesics; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Doxorubicin; Functional Food; Mice, Inbred BALB C; Squalene; Substance P | 2019 |
NF-κB Phosphorylation Inhibition Prevents Articular Cartilage Degradation in Osteoarthritis Rats via 2-Aminoquinoline.
Topics: Aminoquinolines; Animals; Cartilage, Articular; Cytokines; Dinoprostone; Edema; Extremities; Joints; Male; Matrix Metalloproteinase 13; NF-kappa B; Osteoarthritis; Phosphorylation; Rats, Wistar; Receptors, Purinergic P2X7; Signal Transduction; Substance P | 2020 |
Ferulic acid alleviates sciatica by inhibiting peripheral sensitization through the RhoA/p38MAPK signalling pathway.
Topics: Animals; Anti-Inflammatory Agents; Coumaric Acids; Cyclooxygenase 2; Dinoprostone; Guanosine Triphosphate; Hyperalgesia; Interleukin-6; Lipopolysaccharides; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sciatica; Substance P; Tumor Necrosis Factor-alpha | 2022 |
[Visual acupotomy intervention mitigates pain reaction by improving intervertebral disc degeneration and inhibiting apoptosis of nucleus pulposus cells in rabbits with cervical spondylosis].
Topics: Acupuncture Therapy; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Dinoprostone; Intervertebral Disc Degeneration; Male; Meloxicam; Nucleus Pulposus; Pain; Proto-Oncogene Proteins c-bcl-2; Rabbits; Serotonin; Spondylosis; Substance P | 2022 |
H
Topics: Dinoprostone; Humans; Hydrogen Peroxide; Reactive Oxygen Species; Substance P; Transient Receptor Potential Channels; TRPA1 Cation Channel; Urinary Bladder | 2023 |